Mammographic density and candidate gene variants: A twins and sisters study

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 7, 2007, Pages 1479-1484

  Stone, Jennifer ^a   Gurrin, Lyle C ^a   Byrnes, Graham B ^a   Schroen, Christopher J ^a   Treloar, Susan A ^b   Padilla, Emma J D ^c   Dite, Gillian S ^a   Southey, Melissa C ^a   Hayes, Vanessa M ^c   Hopper, John L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HSD3B1 PROTEIN; IGFBP3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; FEMALE; FISHER EXACT TEST; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MONOZYGOTIC TWINS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; STUDENT T TEST; TWINS;

3-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGED; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA-BINDING PROTEINS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ERBB-2; SIBLINGS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; VARIATION (GENETICS); XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 34447550296     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0107     Document Type: Article

References (21)

1. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
2. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
3. Stone J, Dite GS, Gunasekara A, et al. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev 2006;15:612-7.
4. Haiman CA, Bernstein L, Berg D, et al. Genetic determinants of mammographic density. Breast Cancer Res 2002;4:R5.
5. Haiman CA, Hankinson SE, De Vivo I, et al. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 2003;77:27-36.
6. Hong CC, Thompson HJ, Jiang C, et al. Val158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:838-47.
7. Lai JH, Vesprini D, Zhang W, et al. A polymorphic locus in the promoter region of the IGFBP3gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 2004;13:573-82.
8. Maskarinec G, Lurie G, Williams AE, Le Marchand L. An investigation of mammographic density and gene variants in healthy women. Int J Cancer 2004;112:683-8.
9. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. Automated analysis of mammographic densities. Phys Med Biol 1996;41:909-23.
10. Stone J, Gunasekara A, Martin LJ, et al. The detection of change in mammographic density. Cancer Epidemiol Biomarkers Prev 2003;12:625-30.
11. Goldsmith H. A zygosity questionnaire for young twins: a research note. Behav Genet 1991;21:257-69.
12. Spitzer E, Moutier R, Reed T, et al. Comparative diagnoses of twin zygosity by SSLP variant analysis, questionnaire, and dermatoglyphic analysis. Behav Genet 1996;26:55-63.
13. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma) 1979;28:225-36.
14. Lange K, Boehnke M, Weeks D. Programs for pedigree analysis. Los Angeles: Department of Biomathematics, University of California; 1987.
15. Baxter SW, Campbell IG. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.[comment]. J Natl Cancer Inst 2001;93:557-9.
16. Byrne C, Hankinson SE, Pollak M, et al. Insulin-like growth factors and mammographic density. Growth Horm IGF Res 2000;10:S24-5.
17. Diorio C, Berube S, Byrne C, et al. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res 2006;66:588-97.
18. Maskarinec G, Williams AE, Kaaks R. A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 2003;107:991-6.
19. Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
20. Tang D, Cho S, Rundle A, et al. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 2002;75:159-66.
21. Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2004;13:583-91.